Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Kinase, putative | 0.0095 | 0.1523 | 0.5 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0129 | 0.2612 | 0.5 |
Echinococcus multilocularis | Nuclear pore complex protein Nup153 | 0.0129 | 0.2612 | 0.1687 |
Leishmania major | hypothetical protein, conserved | 0.0129 | 0.2612 | 0.5 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0364 | 1 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0364 | 1 | 1 |
Schistosoma mansoni | zinc finger protein | 0.0129 | 0.2612 | 0.0654 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0129 | 0.2612 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0364 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0364 | 1 | 1 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0129 | 0.2612 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0129 | 0.2612 | 0.2612 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0129 | 0.2612 | 0.1764 |
Loa Loa (eye worm) | hypothetical protein | 0.0211 | 0.5175 | 0.5175 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0211 | 0.5175 | 0.4309 |
Schistosoma mansoni | RNA binding protein | 0.0129 | 0.2612 | 0.0654 |
Leishmania major | hypothetical protein, conserved | 0.0129 | 0.2612 | 0.5 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0129 | 0.2612 | 0.5 |
Toxoplasma gondii | Zn-finger in Ran binding protein and others domain-containing protein | 0.0129 | 0.2612 | 0.1285 |
Echinococcus multilocularis | zinc finger protein Ran binding | 0.0129 | 0.2612 | 0.1687 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0129 | 0.2612 | 0.5 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0129 | 0.2612 | 0.5 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0129 | 0.2612 | 0.1764 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0364 | 1 | 1 |
Brugia malayi | TAZ zinc finger family protein | 0.0113 | 0.2095 | 0.1187 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0211 | 0.5175 | 0.4309 |
Toxoplasma gondii | ran binding protein | 0.0129 | 0.2612 | 0.1285 |
Onchocerca volvulus | 0.0129 | 0.2612 | 0.1285 | |
Trichomonas vaginalis | bromodomain containing protein, putative | 0.0131 | 0.2678 | 0.1363 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0131 | 0.2678 | 0.1363 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0129 | 0.2612 | 0.5 |
Schistosoma mansoni | TRABID protein (C64 family) | 0.0129 | 0.2612 | 0.0654 |
Entamoeba histolytica | bromodomain-containing protein | 0.0095 | 0.1523 | 0.5 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0129 | 0.2612 | 0.5 |
Onchocerca volvulus | Ubiquitin thioesterase ZRANB1 homolog | 0.0129 | 0.2612 | 0.1285 |
Loa Loa (eye worm) | hypothetical protein | 0.0129 | 0.2612 | 0.2612 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0364 | 1 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0129 | 0.2612 | 0.5 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0131 | 0.2678 | 0.1363 |
Schistosoma mansoni | brg-1 associated factor | 0.0364 | 1 | 1 |
Echinococcus granulosus | CREB binding protein | 0.0113 | 0.2095 | 0.1315 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0129 | 0.2612 | 0.5 |
Chlamydia trachomatis | SWIB complex protein | 0.0364 | 1 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0364 | 1 | 1 |
Echinococcus multilocularis | Zinc finger, RanBP2 type | 0.0129 | 0.2612 | 0.1687 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0129 | 0.2612 | 0.1764 |
Echinococcus multilocularis | Bromodomain containing protein | 0.0095 | 0.1523 | 0.0461 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0129 | 0.2612 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0364 | 1 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0211 | 0.5175 | 0.4621 |
Onchocerca volvulus | 0.0129 | 0.2612 | 0.1285 | |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0364 | 1 | 1 |
Schistosoma mansoni | fusion | 0.0129 | 0.2612 | 0.0654 |
Onchocerca volvulus | 0.0364 | 1 | 1 | |
Echinococcus granulosus | Nuclear pore complex protein Nup153 | 0.0129 | 0.2612 | 0.1884 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0129 | 0.2612 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0364 | 1 | 0.5 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0364 | 1 | 1 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0364 | 1 | 0.5 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0364 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0116 | 0.2186 | 0.0782 |
Onchocerca volvulus | 0.0129 | 0.2612 | 0.1285 | |
Entamoeba histolytica | bromodomain-containing protein | 0.0095 | 0.1523 | 0.5 |
Brugia malayi | YY1-associated factor 2 | 0.0129 | 0.2612 | 0.1764 |
Leishmania major | hypothetical protein, conserved | 0.0129 | 0.2612 | 0.5 |
Loa Loa (eye worm) | CBP-B | 0.0083 | 0.1141 | 0.1141 |
Loa Loa (eye worm) | hypothetical protein | 0.0129 | 0.2612 | 0.2612 |
Schistosoma mansoni | bromodomain-containing protein 3 brd3 | 0.0211 | 0.5175 | 0.3897 |
Loa Loa (eye worm) | brahma associated protein | 0.0364 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0129 | 0.2612 | 0.5 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0129 | 0.2612 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0129 | 0.2612 | 0.5 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0129 | 0.2612 | 0.1764 |
Echinococcus granulosus | Zinc finger RanBP2 type | 0.0129 | 0.2612 | 0.1884 |
Echinococcus granulosus | zinc finger protein Ran binding | 0.0129 | 0.2612 | 0.1884 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0364 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0364 | 1 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0211 | 0.5175 | 0.4621 |
Leishmania major | hypothetical protein, conserved | 0.0129 | 0.2612 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0364 | 1 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0364 | 1 | 1 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0095 | 0.1523 | 0.1523 |
Loa Loa (eye worm) | hypothetical protein | 0.0129 | 0.2612 | 0.2612 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0131 | 0.2678 | 0.1363 |
Loa Loa (eye worm) | hypothetical protein | 0.0129 | 0.2612 | 0.2612 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0364 | 1 | 1 |
Echinococcus multilocularis | ring and YY1 binding protein | 0.0129 | 0.2612 | 0.1687 |
Schistosoma mansoni | hypothetical protein | 0.0129 | 0.2612 | 0.0654 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0131 | 0.2678 | 0.1363 |
Onchocerca volvulus | 0.0129 | 0.2612 | 0.1285 | |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0364 | 1 | 1 |
Echinococcus granulosus | bromodomain containing 2 | 0.0211 | 0.5175 | 0.4699 |
Echinococcus multilocularis | bromodomain containing 2 | 0.0211 | 0.5175 | 0.4571 |
Entamoeba histolytica | bromodomain-containing protein | 0.0095 | 0.1523 | 0.5 |
Echinococcus granulosus | ring and YY1 binding protein | 0.0129 | 0.2612 | 0.1884 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0364 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CC50 (ADMET) | = 15.4 uM | Cytotoxicity against human MT4 cells after 5 days by MTT assay | ChEMBL. | 22405288 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.